Unknown

Dataset Information

Anti-PGL-1 Positivity as a Risk Marker for the Development of Leprosy among Contacts of Leprosy Cases: Systematic Review and Meta-analysis.


ABSTRACT:

Background

There is no point of care diagnostic test for infection with M. Leprae or for leprosy, although ELISA anti PGL-1 has been considered and sometimes used as a means to identify infection.

Methods

A systematic review of all cohort studies, which classified healthy leprosy contacts, at entry, according to anti-PGL1 positivity, and had at least one year follow up. The outcome was clinical diagnosis of leprosy by an experienced physician. The meta-analysis used a fixed model to estimated OR for the association of PGL-1 positivity and clinical leprosy. A fixed model also estimated the sensibility of PGL-1 positivity and positive predictive value.

Results

Contacts who were anti PGL-1 positive at baseline were 3 times as likely to develop leprosy; the proportion of

SUBMITTER: Penna ML 

PROVIDER: S-EPMC4871561 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature